NTRA Latest Headlines

Natera (NTRA) Receives a Buy from Morgan Stanley

at www.tipranks.com (Mon, 10-Aug 8:25 AM)

Cathie Wood loads up SpaceX, AI infra names, continues trimming Roblox, Palantir

at seekingalpha.com (Mon, 10-Aug 5:55 AM)

Natera Earns Buy Rating on Surging Signatera Demand, Raised Revenue Outlook, and Multi-Year Growth Visibility

at www.tipranks.com (Fri, 7-Aug 1:25 PM)

Piper Sandler Sticks to Its Buy Rating for Natera (NTRA)

at www.tipranks.com (Fri, 7-Aug 11:28 AM)

Evercore ISI Remains a Buy on Natera (NTRA)

at www.tipranks.com (Fri, 7-Aug 8:45 AM)

At a glance: stocks gapping up premarket

at seekingalpha.com (Fri, 7-Aug 7:25 AM)

Wells Fargo Issues a Hold Rating on Natera (NTRA)

at www.tipranks.com (Fri, 7-Aug 7:17 AM)

RBC Capital Sticks to Their Buy Rating for Natera (NTRA)

at www.tipranks.com (Fri, 7-Aug 7:10 AM)

Natera (NTRA) Gets a Buy from Citi

at www.tipranks.com (Fri, 7-Aug 7:09 AM)

J.P. Morgan Sticks to Their Buy Rating for Natera (NTRA)

at www.tipranks.com (Fri, 7-Aug 6:58 AM)

Analysts Are Bullish on These Healthcare Stocks: Immunocore Holdings (IMCR), Natera (NTRA)

at www.tipranks.com (Fri, 7-Aug 1:20 AM)

Natera GAAP EPS of -$0.47 beats by $0.04, revenue of $752.75M beats by $91.46M

at seekingalpha.com (Thu, 6-Aug 4:41 PM)

Signatera Gains First-in-Japan Regulatory Nod for Colorectal Cancer—Backed by Robust Clinical Data and Broad Partnerships

Market Chameleon (Wed, 24-Jun 9:40 AM)

Natera’s Enhanced Panorama NIPT Sets New Standard With 100% Sensitivity for Trisomy 21 and 0.5% No-Call Rate

Market Chameleon (Tue, 26-May 8:16 AM)

FDA Approval Sets New Standard: Natera’s Signatera CDx Paves the Way for Personalized Bladder Cancer Care

Market Chameleon (Mon, 18-May 8:14 AM)